Emmes Launches Third Generation Version of Advantage eClinical

May 11, 2022

Article

Emmes has announced the launch its third generation version of Advantage eClinical. The cloud platform will be available as a standalone software product after undergoing more than two years of development. The system has been specifically designed to provide fast study builds, greater flexibility, and insights to clinical trial sponsors of all sizes.

Related Content

Long-Term KATHERINE Trial Analysis Shows Kadcyla Significantly Improves Survival in HER2-Positive Early Breast Cancer

Davy James

January 16th 2025

Article

An updated long-term analysis of the Phase III KATHERINE trial confirms that adjuvant treatment with Kadcyla (trastuzumab emtansine) significantly improves overall survival and long-term invasive disease–free survival compared to trastuzumab monotherapy in patients with HER2-positive early breast cancer with residual invasive disease.

Our Top 5 Podcast Episodes of 2024

Miranda Schmalfuhs

December 27th 2024

Podcast

The top five episodes of our podcast in the year 2024, highlighted.

Study Shows ePRO Monitoring System Enhances Patient-Centered Care with Improved Communication, Treatment Clarity

Davy James

January 15th 2025

Article

Pilot trial shows that a user-friendly electronic patient-reported outcome (ePRO) monitoring system significantly improves patient-centered cardiovascular care by enhancing patient-physician communication, increasing clarity in treatment explanations, and empowering patients with better knowledge of their conditions.

Driving Diversity with the Integrated Research Model

Andy Studna, Senior Editor

October 16th 2024

Podcast

Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.